Showing results (481-490 of 515) with videos related to

Sort By:
Pageof 52
Crohn'S & Colitis 360|May 13, 2024
Economics of Emergency Department Visits by Patients With Inflammatory Bowel Disease: A Real-World AnalysisKofi Clarke, Arsh Momin, Michelle Rosario, et al.
Crohn'S & Colitis 360|May 9, 2024
Clinical Decision Making in Inflammatory Bowel Disease Mimics: Practice Management from Inflammatory Bowel Disease LIVEHannah W Fiske, Christopher Ward, Samir A Shah, et al.
Crohn'S & Colitis 360|April 29, 2024
Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentric Observational StudyRogério Serafim Parra, Júlio Maria Fonseca Chebli, Matheus Freitas Cardoso de Azevedo, et al.
Crohn'S & Colitis 360|April 10, 2024
Toward Patient Centricity: Why Do Patients With Inflammatory Bowel Disease Participate in Pharmaceutical Clinical Trials? A Mixed-Methods Exploration of Study ParticipantsVirginia Solitano, Heather Prins, Meagan Archer, et al.
Crohn'S & Colitis 360|October 23, 2023
Abdominal Pain in Inflammatory Bowel Disease: An Evidence-Based, Multidisciplinary ReviewMatthew D Coates, Kofi Clarke, Emmanuelle Williams, et al.
Crohn'S & Colitis 360|September 4, 2023
Economic Burden of Fatigue in Inflammatory Bowel DiseaseAshwin N Ananthakrishnan, Raj Desai, Wan-Ju Lee, et al.
Crohn'S & Colitis 360|September 11, 2023
Low Occurrence of Colectomy With Long-Term (up to 4 Years) Golimumab Treatment in Patients With Moderate-to-Severe Active Ulcerative Colitis: Data From the PURSUIT Maintenance and Long-Term Extension StudiesCindy L J Weinstein, Alan G Meehan, Marinella Govoni, et al.
Crohn'S & Colitis 360|June 15, 2026
A multicentered retrospective cohort study comparing JAK inhibitor therapies in moderate-to-severe ulcerative colitisAditi Kumar, Joshua Baxter, Peter Rimmer, et al.
Crohn'S & Colitis 360|February 13, 2023
Functional Medicine Approach to Patient Care Improves Sleep, Fatigue, and Quality of Life in Patients With Inflammatory Bowel DiseaseThomas M Strobel, Christine Nguyen, Taylor Riggs, et al.
Crohn'S & Colitis 360|July 12, 2026
Clinical characterization and healthcare burden of difficult-to-treat inflammatory bowel disease in Latin America: a real-world registry-based studyJesus K Yamamoto-Furusho, Renata Fróes, Cristina Flores, et al.
Pageof 52